Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease
April 21, 2015 at 09:03 AM EDT
Genzyme, a Sanofi company, announced today that patients have begun treatment in a Phase 2a clinical trial focused on evaluating the ...
